MEDP
Medpace Holdings, Inc. Common Stock
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Best Diagnostics Stocks 2026 →
Medpace (MEDP) Stock: Buy, Sell, or Hold?
$653.94
-2.90 (-0.44%)
âŧ
5d:
+0.13%
30d:
+4.03%
90d:
+9.52%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 21, 2026
0d
Protect MEDP Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
49/100
Position
FAIR
30-Day Fair Range
$617.56 â $669.52
Position: FAIR
Forward P/E & Valuation
32.9x
FAIR
vs 29.1x historical avg
Wall Street Target
$651.31
-0.4% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$632.11 / $679.18
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: MEDP is fairly priced but lacks strong directional signals. At 4.2% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Get Alerted When MEDP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$665.51
Based on 6.1% avg growth
INTRINSIC VALUE TODAY
$413.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MEDP is currently trading at $653.94, which is considered fair relative to its 30-day fair value range of $617.56 to $669.52. From a valuation perspective, the stock is trading at a premium (Forward PE: 32.9) compared to its historical average (29.1). At these levels, the market is pricing in 4.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MEDP is in a strong uptrend. Immediate support is located at $632.11, while resistance sits at $679.18.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MEDP is in a strong uptrend. Immediate support is located at $632.11, while resistance sits at $679.18.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$617.56 -
$669.52
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.6%
Trading Range & Key Levels
30-Day Trading Range
$617.56 -
$669.52
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$32.29
(4.9%)
Support Level
$632.11
Resistance Level
$679.18
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding MEDP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($651.31)
- NEUTRAL: Market pricing in 4.2% annual earnings growth - fairly valued
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
32.94
Wall Street Target
$651.31
(-0.4%)
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
25.4%
Profit Margin
18.2%
Valuation Premium vs History
+4.2% premium
PE vs Historical
32.9 vs 29.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.2%
(market-implied from PE analysis)
1-Year Target
$681.41
(+4%)
2-Year Target
$710.02
(+9%)
3-Year Target
$739.85
(+13%)
3-Yr Target (if PE normalizes)
(PE: 33â29)
PE COMPRESSION
$653.67
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 32.9, Growth: 8.1%)
$827.00
(+27%)
Base:
(SPY PE: 19.9, Growth: 8.1%)
$498.66
(-24%)
Bear:
(PE: 16.9, Growth: 8.1%)
$423.86
(-35%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (33x PE) as earnings recover.
Trailing PE: 35.92 | Current EPS (TTM): $18.01
Bull Case
$784.56
(+20%)
Analyst growth 10.2%, PE expands to 39.5
Base Case
$713.23
(+9%)
Market implied 10.2%, PE stable at 35.9
Bear Case
$439.94
(-33%)
Severe decline -20.0%, PE contracts to 30.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share MEDP Analysis
Share this live MEDP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MEDP)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 15, 2026
Daily AI digest
AI Retail Discussion Summary:
A user on StockTwits with 946 followers is expressing bullish sentiment towards $MEDP, as the company is set to release earnings next week and the stock has broken above its 50-day moving average.
Key Retail Themes:
earnings release
technical analysis
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 6:15 PM ET
Data refreshes hourly during market hours. Next update: 7:15 PM
Data refreshes hourly during market hours. Next update: 7:15 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MEDP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 57 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 67 BUY |
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
27 analysts |
$752 | 52 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 52 HOLD |
Advanced MEDP Option Strategies
Professional options setups generated by AI based on today's MEDP price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MEDP Research Pages
